Home > Research > Publications & Outputs > Fitting models for the joint action of two drug...
View graph of relations

Fitting models for the joint action of two drugs using SAS(R).

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Fitting models for the joint action of two drugs using SAS(R). / Whitehead, Anne; Whitehead, John; Todd, Susan et al.
In: Pharmaceutical Statistics, Vol. 7, No. 4, 10.2008, p. 272-284.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Whitehead, A, Whitehead, J, Todd, S, Zhou, Y & Smith, MK 2008, 'Fitting models for the joint action of two drugs using SAS(R).', Pharmaceutical Statistics, vol. 7, no. 4, pp. 272-284. https://doi.org/10.1002/pst.312

APA

Whitehead, A., Whitehead, J., Todd, S., Zhou, Y., & Smith, M. K. (2008). Fitting models for the joint action of two drugs using SAS(R). Pharmaceutical Statistics, 7(4), 272-284. https://doi.org/10.1002/pst.312

Vancouver

Whitehead A, Whitehead J, Todd S, Zhou Y, Smith MK. Fitting models for the joint action of two drugs using SAS(R). Pharmaceutical Statistics. 2008 Oct;7(4):272-284. doi: 10.1002/pst.312

Author

Whitehead, Anne ; Whitehead, John ; Todd, Susan et al. / Fitting models for the joint action of two drugs using SAS(R). In: Pharmaceutical Statistics. 2008 ; Vol. 7, No. 4. pp. 272-284.

Bibtex

@article{978d2995deb744c6a6c6f2f56d6a4411,
title = "Fitting models for the joint action of two drugs using SAS(R).",
abstract = "Combinations of drugs are increasingly being used for a wide variety of diseases and conditions. A pre-clinical study may allow the investigation of the response at a large number of dose combinations. In determining the response to a drug combination, interest may lie in seeking evidence of synergism, in which the joint action is greater than the actions of the individual drugs, or of antagonism, in which it is less. Two well-known response surface models representing no interaction are Loewe additivity and Bliss independence, and Loewe or Bliss synergism or antagonism is defined relative to these. We illustrate an approach to fitting these models for the case in which the marginal single drug dose-response relationships are represented by four-parameter logistic curves with common upper and lower limits, and where the response variable is normally distributed with a common variance about the dose-response curve. When the dose-response curves are not parallel, the relative potency of the two drugs varies according to the magnitude of the desired effect and the models for Loewe additivity and synergism/antagonism cannot be explicitly expressed. We present an iterative approach to fitting these models without the assumption of parallel dose-response curves. A goodness-of-fit test based on residuals is also described. Implementation using the SAS NLIN procedure is illustrated using data from a pre-clinical study.",
keywords = "antagonism • Bliss independence • dose-response surface • drug combination • Loewe additivity • synergy",
author = "Anne Whitehead and John Whitehead and Susan Todd and Yinghui Zhou and Smith, {Michael K.}",
year = "2008",
month = oct,
doi = "10.1002/pst.312",
language = "English",
volume = "7",
pages = "272--284",
journal = "Pharmaceutical Statistics",
issn = "1539-1604",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

RIS

TY - JOUR

T1 - Fitting models for the joint action of two drugs using SAS(R).

AU - Whitehead, Anne

AU - Whitehead, John

AU - Todd, Susan

AU - Zhou, Yinghui

AU - Smith, Michael K.

PY - 2008/10

Y1 - 2008/10

N2 - Combinations of drugs are increasingly being used for a wide variety of diseases and conditions. A pre-clinical study may allow the investigation of the response at a large number of dose combinations. In determining the response to a drug combination, interest may lie in seeking evidence of synergism, in which the joint action is greater than the actions of the individual drugs, or of antagonism, in which it is less. Two well-known response surface models representing no interaction are Loewe additivity and Bliss independence, and Loewe or Bliss synergism or antagonism is defined relative to these. We illustrate an approach to fitting these models for the case in which the marginal single drug dose-response relationships are represented by four-parameter logistic curves with common upper and lower limits, and where the response variable is normally distributed with a common variance about the dose-response curve. When the dose-response curves are not parallel, the relative potency of the two drugs varies according to the magnitude of the desired effect and the models for Loewe additivity and synergism/antagonism cannot be explicitly expressed. We present an iterative approach to fitting these models without the assumption of parallel dose-response curves. A goodness-of-fit test based on residuals is also described. Implementation using the SAS NLIN procedure is illustrated using data from a pre-clinical study.

AB - Combinations of drugs are increasingly being used for a wide variety of diseases and conditions. A pre-clinical study may allow the investigation of the response at a large number of dose combinations. In determining the response to a drug combination, interest may lie in seeking evidence of synergism, in which the joint action is greater than the actions of the individual drugs, or of antagonism, in which it is less. Two well-known response surface models representing no interaction are Loewe additivity and Bliss independence, and Loewe or Bliss synergism or antagonism is defined relative to these. We illustrate an approach to fitting these models for the case in which the marginal single drug dose-response relationships are represented by four-parameter logistic curves with common upper and lower limits, and where the response variable is normally distributed with a common variance about the dose-response curve. When the dose-response curves are not parallel, the relative potency of the two drugs varies according to the magnitude of the desired effect and the models for Loewe additivity and synergism/antagonism cannot be explicitly expressed. We present an iterative approach to fitting these models without the assumption of parallel dose-response curves. A goodness-of-fit test based on residuals is also described. Implementation using the SAS NLIN procedure is illustrated using data from a pre-clinical study.

KW - antagonism • Bliss independence • dose-response surface • drug combination • Loewe additivity • synergy

U2 - 10.1002/pst.312

DO - 10.1002/pst.312

M3 - Journal article

VL - 7

SP - 272

EP - 284

JO - Pharmaceutical Statistics

JF - Pharmaceutical Statistics

SN - 1539-1604

IS - 4

ER -